Birju Mehta

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma”.

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

Nature Communications(2020)10.1038/s41467-020-17175-8

N/A

4.1DataRank · unranked

169 citations

Sujith K. Joseph, Farzana Pashankar, Christopher DeRenzo, Khaled Sanber, Shoba A. Navai +20 more

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

Journal of Clinical Oncology(2024)10.1200/jco.23.02019

N/A

1.8DataRank · unranked

75 citations

Austin J. Stuckert, Candise Tat, Mark D. White, Lucia Ruggieri, Huimin Zhang +30 more

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Nature Cancer(2024)10.1038/s43018-024-00749-6

N/A

1.5DataRank · unranked

87 citations

Shoba A. Navai, Christopher DeRenzo, Sujith K. Joseph, Khaled Sanber, Meng‐Fen Wu +32 more

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

UNC Libraries(2024)10.17615/xykw-ba83

N/A

0DataRank · unranked

1 citations

Riyue Bao, Meenakshi Hegde, Zeid Nawas, Rikhia Chakraborty, Birju Mehta +32 more

Autologous HER2-specific CAR T-cells after lymphodepletion for advanced sarcoma

Research Square(2023)10.21203/rs.3.rs-2409436/v1

N/A

0DataRank · unranked

0 citations

Shoba A. Navai, Christpher DeRenzo, Sujith K. Joseph, Khaled Sanber, Meng‐Fen Wu +28 more

Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006267

N/A

0DataRank · unranked

11 citations

Mae Woods, Naren Mehta, Tim Sauer, Kathan Parikh, Michael Schmueck‐Henneresse +6 more

Enhanced anti-tumor activity of CD5 CAR T cells manufactured with tyrosine kinase inhibitors in patients with relapsed/refractory T-ALL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7002

N/A

0DataRank · unranked

12 citations

Rayne H. Rouce, Tyler S. Smith, Blakely Boriskie, Madhuwanti Srinivasan, Sachin G. Thakkar +8 more